ITI Focused Fund
The scheme seek to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 companies across market capitalization.
Growthvine rating: 2/5 — ranked #16 of 28 in category.
Fund basics
| Category | Equity: Focused |
|---|
| NAV | ₹16.68 (as of 2026-08-21) |
|---|
| AUM | ₹597 Cr |
|---|
| Expense ratio | 2.06% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Alok Ranjan |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Sharpe ratio | 0.69 |
|---|
| Standard deviation | 16.32% |
|---|
| Max drawdown | -19.04% |
|---|
| Alpha | 4.41 |
|---|
| Beta | 1.03 |
|---|
Over 5 years, captured 107.7% of Nifty 500's upside and 89.2% of its downside.
Market cap allocation
| Large cap | 60.3% |
|---|
| Mid cap | 20.1% |
|---|
| Small cap | 19.7% |
|---|
Concentration
| Top 5 holdings | 22.9% |
|---|
| Top 10 holdings | 42.1% |
|---|
| Total holdings | 28 |
|---|
| Index overlap | 29.4% |
|---|
| Active share | 70.6% |
|---|
Top holdings
- ICICI Bank Ltd. — 5.2%
- Net Receivables / (Payables) — 4.8%
- Solar Industries India Limited — 4.5%
- HDFC Bank Ltd. — 4.4%
- Vedanta Aluminium Metal Limited — 4.4%
- Reliance Industries Ltd — 4.4%
- KRN HEAT EXCHANGER AND REFRIGERATION LIMITED — 4.2%
- Wockhardt Ltd — 3.9%
- Multi Commodity Exchange of India Ltd — 3.9%
- Fortis Healthcare Ltd — 3.6%
Top sectors
- Banking & Financial — 17.1%
- Industrial Products — 13.2%
- Pharma & Biotech — 7.4%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 5.0% | Q2 | #8 of 28 |
| 2025 | 7.7% | Q1 (Top) | #7 of 28 |
| 2024 | 24.5% | Q1 (Top) | #4 of 27 |